4//SEC Filing
Vaughn James J 4
Accession 0001209191-19-056635
CIK 0001131324other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 9:41 PM ET
Size
24.7 KB
Accession
0001209191-19-056635
Insider Transaction Report
Form 4
Vaughn James J
Chief Commercial Officer
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−5,142→ 0 totalExercise: $27.00Exp: 2026-02-16→ Common Stock (5,142 underlying) - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−16,900→ 0 totalExercise: $27.48Exp: 2027-01-31→ Common Stock (16,900 underlying) - Disposition to Issuer
Common Stock
2019-11-08−11,281→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−18,027→ 16,900 totalExercise: $27.48Exp: 2027-01-31→ Common Stock (18,027 underlying) - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−13,376→ 26,331 totalExercise: $33.21Exp: 2028-01-31→ Common Stock (13,376 underlying) - Disposition to Issuer
Common Stock
2019-11-08−5,249→ 11,281 total - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−17,739→ 5,142 totalExercise: $27.00Exp: 2026-02-16→ Common Stock (17,739 underlying) - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−26,331→ 0 totalExercise: $33.21Exp: 2028-01-31→ Common Stock (26,331 underlying) - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−9,530→ 0 totalExercise: $72.52Exp: 2029-01-29→ Common Stock (9,530 underlying)
Footnotes (9)
- [F1]Disposed of in connection with the acquisition of Issuer (the "Merger") by Exact Sciences Corporation ("Exact Sciences") pursuant to the Agreement and Plan of Merger, dated July 28, 2019 (the "Merger Agreement"), among Exact Sciences,Spring Acquisition Corp., and Issuer, whereby such shares of Issuer common stock were cancelled and converted into the right to receive a cash payment of $144,374 and 2,364 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F2]Disposed of in connection with the Merger, whereby such Issuer Restricted Stock Unit ("RSU") was assumed by Exact Sciences and converted into a corresponding award for 8,632 RSUs of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F3]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $290,755, less applicable tax withholdings, and 4,762 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F4]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 3,935 shares of Exact Sciences common stock with an exercise price of $35.28 per share.
- [F5]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $291,915, less applicable tax withholdings, and 4,781 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F6]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 12,935 shares of Exact Sciences common stock with an exercise price of $35.91 per share.
- [F7]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $185,065, less applicable tax withholdings, and 3,031 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F8]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 20,151 shares of Exact Sciences common stock with an exercise price of $43.40 per share.
- [F9]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 7,293 shares of Exact Sciences common stock with an exercise price of $94.76 per share.
Documents
Issuer
GENOMIC HEALTH INC
CIK 0001131324
Entity typeother
Related Parties
1- filerCIK 0001649689
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 9:41 PM ET
- Size
- 24.7 KB